Particularly, the ESR1 mutation dramatically shifts the distribution of metastatic breast cancer destinations with a sharp increase in the liver (from 52% to 75%) accompanied by fractional decreases in brain and lung (p < 0.0001, Chi-squared test, Fig. 5b). This evidence concerns the gene ESR1 and breast cancer.